Guobang Pharma Ltd. (SHA:605507)

Guobang Pharma Revenue

Guobang Pharma had revenue of 1.45B CNY in the quarter ending September 30, 2026, with 0.19% growth. This brings the company's total for the last twelve months to 6.13B, up 3.16% year-over-year. In the year 2025, Guobang Pharma had annual revenue of 6.01B with 2.05% growth. That makes Guobang Pharma the 8,025th largest company in the world by revenue and 1,213th in China.

• Revenue (ttm): 6.13B
• Revenue Growth: +3.16%
• P/S Ratio: 1.98
• Revenue / Employee: 1.44M
• Employees: 4,251
• Market Cap: 12.11B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 3.30B 55.1%
• Overseas 2.69B 44.9%

Fiscal year ended Dec 31, 2025 See the full Guobang Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.01B	120.56M	2.05%
Dec 31, 2024	5.89B	541.39M	10.12%
Dec 31, 2023	5.35B	-371.48M	-6.49%
Dec 31, 2022	5.72B	1.22B	26.98%
Dec 31, 2021	4.51B	299.03M	7.11%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error